Company news
Hyperfine, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Hyperfine, Inc. to Announce First Quarter Financial Results on May 11, 2023
April 19, 2023
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
March 20, 2023
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
March 5, 2023
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging
February 27, 2023
Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations
February 20, 2023
Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System
February 12, 2023
Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer
February 7, 2023
Hyperfine Reports Third Quarter 2022 Financial Results
November 9, 2022
Hyperfine to Announce Third Quarter 2022 Financial Results on November 10, 2022
October 26, 2022
Hyperfine Names Maria Sainz President and Chief Executive Officer
October 5, 2022
Hyperfine Reports Second Quarter 2022 Financial Results
August 9, 2022
Hyperfine to Announce Second Quarter 2022 Financial Results on August 10, 2022
July 19, 2022
Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients
July 13, 2022
Hyperfine Announces CEO Transition
June 28, 2022
Hyperfine Announces Expansion into Australia and New Zealand with Medical Device Registration and Notification
June 13, 2022
Hyperfine Reports First Quarter 2022 Financial Results
May 10, 2022
Hyperfine to Announce First Quarter 2022 Financial Results on May 11, 2022
April 19, 2022
Hyperfine Reports Fourth Quarter and Full Year 2021 Financial Results
March 22, 2022
Hyperfine to Announce Fourth Quarter and Full Year 2021 Financial Results
March 2, 2022
Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director
February 7, 2022
Hyperfine Reports Preliminary Unaudited 2021 Revenue and Swoop® System Installations
January 9, 2022
Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker "HYPR" on the Nasdaq Global Market
December 21, 2021
Hyperfine, Liminal Sciences, and HealthCor Catalio Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
November 28, 2021
Calls
The 5 newest of 19 calls. Every call is listed under its year.
- Hyperfine (NASDAQ:HYPR) Q2 2026 Earnings Call
Aug 6, 2026
Transcript - Hyperfine (NASDAQ:HYPR) Q1 2026 Earnings Call
May 12, 2026
Transcript - Hyperfine (NASDAQ:HYPR) Q4 2025 Earnings Call
Mar 18, 2026
Transcript - Hyperfine (NASDAQ:HYPR) Q3 2025 Earnings Call
Nov 13, 2025
Transcript - Hyperfine (NASDAQ:HYPR) Q2 2025 Earnings Call
Aug 13, 2025
Transcript
Decks
The 5 newest of 13 decks. Every deck is listed under its year.
- Investor Presentation (October 2026)
Investor deck · 26 slides · Oct 8, 2026
- Q1 2026 Earnings Presentation
Earnings · 21 slides · May 12, 2026
- Investor Presentation (January 2026)
Investor deck · 21 slides · Jan 12, 2026
- Q3 2025 Earnings Presentation
Earnings · 24 slides · Nov 13, 2025
- Investor Presentation (October 2025)
Investor deck · 24 slides · Oct 15, 2025